Resmed expands its board of directors and appoints healthcare executive and seasoned finance leader christopher delorefice to its board

San diego, aug. 15, 2024 (globe newswire) -- resmed (nyse: rmd, asx: rmd) today announced it has expanded the size of its board of directors to 11 and has elected christopher delorefice to the board, effective immediately. mr. delorefice was appointed during resmed's regularly scheduled board meeting on august 15, 2024, and will stand for re-election with the rest of resmed's directors at its annual meeting on november 21, 2024. mr. delorefice has also been appointed as a member of resmed's board audit committee.
RMD Ratings Summary
RMD Quant Ranking